Browse studies, page 1105
Page 1105 of 1,183, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months BJOG : an international journal of obstetrics and gynaecology, 2015
- Pharmaceutical, clinical, and immunohistochemical studies of metformin hydrochloride topical hydrogel for wound healing application Archives of dermatological research, 2020
- Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes Diabetic medicine : a journal of the British Diabetic Association, 2016
- Mental state and health-related quality of life in patients with polycystic ovary syndrome under metformin therapy - a prospective study Journal of psychosomatic obstetrics and gynaecology, 2025
- Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis Diabetic medicine : a journal of the British Diabetic Association, 2018
- No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies Current pharmaceutical design, 2019
- Postpartum Use of Weight Loss and Metformin for the Prevention of Type 2 Diabetes Mellitus: a Review of the Evidence Current diabetes reports, 2021
- Metformin use in kidney transplant recipients in the United States: an observational study American journal of nephrology, 2014
- Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [18F]Fluorodeoxyglucose PET-MRI. Diabetes care, 2020
- Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19 Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2020
- Metformin does not improve survival in patients with hepatocellular carcinoma World journal of gastroenterology, 2014
- Metformin Use and Clinical Outcomes in Very Elderly Patients with Type 2 Diabetes and Chronic Kidney Disease Medicina (Kaunas, Lithuania), 2026
- Treatment of type 2 diabetes mellitus in children and adolescents Journal of pediatric endocrinology & metabolism : JPEM, 2002
- Efficacy and safety of metformin for treatment of type 2 diabetes in elderly Japanese patients Geriatrics & gerontology international, 2011
- Limitations of metformin use in patients with kidney disease: are they warranted? Diabetes, obesity & metabolism, 2010
- Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2 Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016
- Progesterone Suppression of Luteinizing Hormone Pulse Frequency in Adolescent Girls With Hyperandrogenism: Effects of Metformin The Journal of clinical endocrinology and metabolism, 2018
- Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study American journal of kidney diseases : the official journal of the National Kidney Foundation, 2025
- Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2008
- The effect of metformin on responses to chemotherapy and survival in stage IV colorectal cancer with diabetes The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012
- Adherence to metformin and the onset of rheumatoid arthritis: a population-based cohort study Scandinavian journal of rheumatology, 2020
- Risk of Metformin-Associated Lactic Acidosis (MALA) in Patients After Gastric Bypass Surgery Obesity surgery, 2018
- Metformin versus insulin use for treatment of gestational diabetes and delivery by caesarean section: A nationwide Swedish cohort study European journal of obstetrics, gynecology, and reproductive biology, 2020
- Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism Journal of ovarian research, 2021
- Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes International journal of environmental research and public health, 2022
- Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome - a retrospective analysis Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2012
- The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia International braz j urol : official journal of the Brazilian Society of Urology, 2018
- Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels Journal of diabetes, 2016
- Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer Cancer causes & control : CCC, 2018
- Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia Obstetrics and Gynecology, 2024
- Prognostic significance of metformin treatment in endometrial cancer: a meta-analysis Pharmazie, 2020
- Metformin and small for gestational age babies: findings of a randomised placebo-controlled clinical trial of metformin in gestational diabetes (EMERGE) Diabetologia, 2024
- Abstract 4357554: Association between metformin exposure and outcomes in diabetic patients undergoing cardiac surgery: A retrospective cohort study Circulation, 2025
- Effects of metformin use on aneurysmal subarachnoid hemorrhage outcomes Acta Neurochirurgica, 2025
- Fixed-dose Combination of Dapagliflozin and Linagliptin in Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Randomized Double-blind Multicenter Trial Journal of Diabetology, 2025
- Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis International Journal of Cardiology, 2019
- Variants in Pharmacokinetic Transporters and Glycaemic Response to Metformin: A MetGen Meta-Analysis Clinical pharmacology and therapy, 2017
- Benefits and disadvantages of combination therapy with imeglimin and metformin in patients with type 2 diabetes Expert Opinion on Pharmacotherapy, 2025
- Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes Drug Design, Development and Therapy, 2025
- Metformin’s impact on tumor regression grade in diabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy Scientific Reports, 2025
- Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies Canadian Respiratory Journal, 2020
- Glucagon-like Peptide-1 Receptor Agonists and Cardioprotective Benefit in Patients With Type 2 Diabetes Without Baseline Metformin: An Update Meta-analysis 2021
- Composite cardiovascular risk and BMI affected comparative profiles of BIAsp 30 + metformin vs BIAsp 30 monotherapy: a MERIT post-hoc analysis Scientific Reports, 2021
- Dose-Dependent Relationship Between Long-Term Metformin Use and the Risk of Diabetic Retinopathy: A Population-Based Cohort Study Clinical drug investigation, 2025
- Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study Diabetes Therapy, 2020
- Metformin dose increase versus added linagliptin in non‐alcoholic fatty liver disease and type 2 diabetes: An analysis of the J‐LINK study Diabetes, obesity and metabolism, 2020
- Novel antidiabetic drugs and risk of cardiovascular events in patients without baseline metformin use: a meta-analysis European Journal of Preventive Cardiology, 2020
- Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes Annals of Hepatology, 2019
- A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, Stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study Gynecologic Oncology, 2025
- Glucagon-like Peptide-1 Receptor Agonists and Cardioprotective Benefit in Patients with Type 2 Diabetes Without Baseline Metformin: A Systematic Review and Update Meta-analysis High Blood Pressure & Cardiovascular Prevention, 2021
- Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement European Radiology, 2021
- Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis Journal of Diabetes Research, 2019
- Abstract 3482: Correlative analysis of metformin and nivolumab combination in treatment-refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC) Cancer Research, 2022
- Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis Scientific Reports, 2020
- Efficacy of Metformin in Patients With Breast Cancer Receiving Chemotherapy or Endocrine Therapy: Systematic Review and Meta-analysis The Annals of Pharmacotherapy, 2021
- The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis Reproductive Biology and Endocrinology, 2021
- Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials Frontiers in Endocrinology, 2022
- Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis BMJ Open, 2022
- Systematic review and meta-analysis of Coptis chinensis Franch.-containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus Frontiers in Pharmacology, 2022
- Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial Nature Communications, 2025
- Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: A preclinical systematic review and meta-analysis Frontiers in Pharmacology, 2022
- Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis International Journal of Gynecological Cancer, 2021
- Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis Frontiers in Medicine, 2021
- Characterization of changes in HbA1c in patients with and without secondary failure after metformin treatments by a population pharmacodynamic analysis using mixture models Drug Metabolism and Pharmacokinetics, 2018
- Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus BMJ Open Diabetes Research & Care, 2021
- Different effects of metformin and insulin on primary and secondary chemoprevention of colorectal adenoma in diabetes type 2: Traditional and Bayesian meta-analysis EXCLI Journal : Experimental and Clinical Sciences, 2018
- SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise Clinical science, 2020
- Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials BMJ Open, 2023
- Prescription patterns and therapeutic effects of second-line drugs in Japanese patients with type 2 diabetes mellitus: Analysis of claims data for metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycemic agents Expert Opinion on Pharmacotherapy, 2023
- Comparative effects of acupuncture and metformin on insulin sensitivity in overweight/obese and lean women with polycystic ovary syndrome and insulin resistance: a post hoc analysis of a randomized trial Frontiers in Medicine, 2023
- Neoadjuvant metformin on clinical and pathological response in non-diabetic patients with non-metastatic breast cancer: an updated systematic review and meta-analysis Clinical and Translational Oncology, 2026
- Effectiveness of Metformin in Preventing Type 2 Diabetes in Children and Adolescents with Overweight or Obesity: A Protocol for a Systematic Review and Meta-Analysis Obesities, 2026
- Revisiting metformin as a chemotherapy adjuvant: a systematic review and meta-analysis based on recent randomized-controlled trials Frontiers in Oncology, 2026
- Impact of metformin on outcomes with immune checkpoint inhibitors in renal cell carcinoma: A large-scale retrospective analysis Journal of Clinical Oncology, 2026
- Evaluation of Jinlida Granules in Improvements to Standard-Reaching Rate of Blood Glucose and Type 2 Diabetes Mellitus Symptoms: Results of Secondary Analysis From 12-Week Trial 2021
- Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy, 2024
- Metformin use and preeclampsia risk in women with diabetes: a two-country cohort analysis BMC Medicine, 2024
- Metformin Use in Type 2 Diabetics and Delirium After Noncardiac Surgery: A Retrospective Cohort Analysis Anesthesia and Analgesia, 2024
- Efficacy of Metformin for the Treatment of Melasma: A Systematic Review and Meta-analysis of Randomised Controlled Trials Journal of Advanced Trends in Medical Research, 2025
- Secondary analysis of newly diagnosed type 2 diabetes subgroups and treatment responses in the MARCH cohort Diabetes & metabolic syndrome, 2023
- Pioglitazone as Add-On to Metformin and Dapagliflozin Yields Significant Enhancements in Glycemic Control in Poorly Controlled Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials Cureus, 2025
- Effectiveness of Glipizide and Glipizide Plus Metformin Formulation among Asian Indians with Type 2 Diabetes: a Real‐World, Retrospective Electronic Medical Record Analysis Drugs - Real World Outcomes, 2025
- Abstract P131: Individualized Risk Prediction for Type 2 Diabetes: A Secondary Analysis of the Diabetes Prevention Program Circulation, 2024
- Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Secondary analysis of the SPARTAN trial Journal of Clinical Oncology, 2024
- Lactic acidosis secondary to metformin toxicity :a case report Endocrine Abstracts, 2025
- Insulin clearance at randomization and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomized clinical trial Diabetologia, 2024
- 546-P: Effects of Metformin on Heart Rate Variability in Adolescents with Type 1 Diabetes: A Secondary Analysis of a Randomized Crossover-Controlled Trial 2020
- Prices of Anti-Diabetic Drugs Sold in Private Pharmacies in Côte d’Ivoire, 2023: A Secondary Analysis ClinicoEconomics and Outcomes Research, 2025
- Breastfeeding patterns among parturients with diabetes: A secondary analysis of the MOMPOD randomized clinical trial Pregnancy, 2025
- Metformin's therapeutic potential in spinal cord injury: a systematic review and meta-analysis on locomotor recovery, neuropathic pain alleviation, and modulation of secondary injury mechanisms Acta Neurochirurgica, 2025
- Early Metformin for Gestational Diabetes Mellitus Does Not Alter Exclusive Breastfeeding at 12 Weeks: Secondary Analysis of the EMERGE Randomized Trial Diabetes Obesity and Cardiometabolic CARE, 2026
- Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302 European Journal of Cancer, 2022
- Low BMI patients with advanced EGFR mutation-positive NSCLC can get a better outcome from metformin plus EGFR-TKI as first-line therapy: A secondary analysis of a phase 2 randomized clinical trial Chinese Medical Journal - Pulmonary and Critical Care Medicine, 2023
- Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial Frontiers in Endocrinology, 2023
- Postnatal Cardiometabolic Health After Metformin Use in Gestational Diabetes: A Secondary Analysis of the EMERGE Trial Journal of Clinical Endocrinology and Metabolism, 2024
- Longitudinal associations of dietary fiber and its source with 48-week weight loss maintenance, cardiometabolic risk factors and glycemic status under metformin or acarbose treatment: a secondary analysis of the March randomized trial Nutrition & Diabetes, 2024
- Glucagon-like receptor-1 agonists and impotence: A meta-analysis World journal of methodology, 2026
- The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care Clinical journal of the American Society of Nephrology : CJASN, 2026
- Effects of GLP-1 Receptor Agonists vs Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Cureus, 2026
- Comparative cardiovascular outcomes and safety of hypoglycemic drug classes in patients with type 2 diabetes and hypertension: a multicenter cohort analysis Cardiovascular diabetology, 2025
